Leukemia Clinical Trials in Detroit

Showing 741-760 of 1,678 trials

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

NCT04198818

This is a First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients with Advanced Tumors, composed of a Phase I dose escalation and dose expansion stage and a Phase II dose extension stage.

Advanced TumorsMelanomaNon-Small-Cell Lung Cancer+2 more

Haihe Biopharma Co., Ltd.37 participantsStarted Jan 2020

Lafayette, Indiana, United States • Detroit, Michigan, United States • Shanghai, China

COMPLETEDNA< 1 mile

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

NCT01029353

This study will compare the effectiveness of two surgical procedures -laparotomy versus drainage - commonly used to treat necrotizing enterocolitis (NEC) or isolated intestinal perforations (IP) in extremely low birth weight infants (≤1,000 g). Infants diagnosed with NEC or IP requiring surgical intervention, will be recruited. Subjects will be randomized to receive either a laparotomy or peritoneal drainage. Primary outcome is impairment-free survival at 18-22 months corrected age.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more

NICHD Neonatal Research Network529 participantsStarted Jan 2010

Birmingham, Alabama, United States • Los Angeles, California, United States • Palo Alto, California, United States +19 more locations

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Leukemia Trials in Other Cities

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

House Dust Mite Allergy Trial In Children

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Testing of a New Therapeutic Vibration Device to Reduce Neuromuscular Weakness in Hospitalized Patients

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Other Conditions in Detroit